cyclovirobuxine D

bebuxine 9,19- cyclo-5-alpha,9-beta-pregnan-16-alpha-ol, 4,4,14-trimethyl-3-beta,20-alpha-bis(methylamino)- 9,19- cyclopregnan-16-ol, 4,4,14-trimethyl-3,20-bis(methylamino)-, (3beta,5alpha,16alpha,20S)- cyclovirobuxin D PubMed: Cyclovirobuxine D Induces Autophagy-Associated Cell Death via the Akt/mTOR Pathway in MCF-7 Human Breast Cancer Cells. PubMed: Experimental and theoretical investigation on the interaction between cyclovirobuxine D and human serum albumin. PubMed: Influence of cyclovirobuxine D on intracellular [Ca(2+)] regulation and the expression of the calcium cycling proteins in rat myocytes. PubMed: [Effects of CVB-D on hemodynamic in anaesthetized dogs in vivo]. PubMed: Beneficial effect of Cyclovirobuxine D on heart failure rats following myocardial infarction. PubMed: Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells. PubMed: [Studies of in vitro releasing properties on cyclovirobuxine D matrix-type patch]. PubMed: Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis. PubMed: Short and efficient approach towards buxozine-C, an alkaloid from Buxus sempervirens. PubMed: [Determination of cyclovirobuxine-D in huangyangning tablets by RP-HPLC with gradient elution]. PubMed: Sensitive HPLC-APCI-MS method for the determination of cyclovirobuxine D in human plasma. PubMed: High performance liquid chromatography - tandem mass spectrometric determination of cyclovirobuxine D in human plasma. PubMed: [Structural modification of cyclovirobuxine D and their inhibition activity on lipid peroxidation]. PubMed: [Prodrug structural modifications of cyclovirobuxine D and their biological activity]. PubMed: Regulation of Ca2+ movements by cyclovirobuxine D in ECV304 endothelial cells. PubMed: [Electrophysiologic study of the biphasic effects of cyclovirobuxine D on arrhythmias]. PubMed: [Effects of cyclovirobuxine D on intracellular Ca2+ and L-type Ca2+ current in rat ventricular cardiomyocytes]. PubMed: [Structural modification and bioactivity of cyclovirobuxine D]. PubMed: [Determination of cyclovirobuxine D by RP-HPLC with precolumn fluorescence derivatization]. PubMed: Coronary effects of cyclovirobuxine D in anesthetized pigs and in isolated porcine coronary arteries. PubMed: Hemodynamic effects of the intravenous administration of cyclovirobuxine D [correction of cyclorirobuxine D] in anesthetized pigs. PubMed: [Anti-atrial fibrillation effects of cyclovirobuxine-D and its electrophysiological mechanism studied on guinea pig atria]. PubMed: Protective effect of cycloprotobuxine-A against cardiac arrhythmias induced by ouabain. PubMed: [Congestive heart failure treated by a combination of cyclovirobuxine D with digoxin]. PubMed: Anti-arrhythmic action of cycloprotobuxine-A. PubMed: The beneficial effects of cyclovirobuxine D (CVBD) in coronary heart disease. A double blind analysis of 110 cases. PubMed: [Double blind study of the therapeutic effect of cyclovirobuxine D No. 1 on the left ventricular function in coronary heart disease]. PubMed: [Clinical observation of 546 cases of coronary heart disease treated with cyclovirobuxine D]. PubMed: [Some cardiovascular effects of cyclovirobuxine-D (author's transl)]. PubMed: [Experimental analysis of the anti-arrhythmic and arrhythmia-inducing actions of cyclovirobuxine D (author's transl)].